Filters

anti-Influenza A H5N1 Vietnam 1203/04 Hemagglutinin (17-338, His-tagged) Antibody

anti-Influenza A H5N1 Vietnam 1203/04 Hemagglutinin (17-338, His-tagged) Antibody size: 0,25 mg 1413

Supplier ACR
Price 1413
Size 0,25 mg
Vial descriptionAvian Influenza A H5N1 H5 Hemagglutinin
Categoryantigen
Raised inlaboratory
Clone1 vial
FormPurified
Reactivitynot determined
Purity>, 90%
Molecular weight37, 4 kDa
Sourcemammalian
Activityto be determined
Rangebroad
Protein numbersee ncbi
Applicationnot determined
Storage Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4°
Description Freeze thaw will destroy a percentage in every cycle and should be avoided, Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, Influenza is an , The cough, These symptoms typically begin two days after exposure to the virus and most last less than a week, and , but these are not common in adults, however, may last for more than two weeks, peptides and antibodies detect a virus commonly known as ", there may be ,  ,  ,  ,  ,  ,  ,  ,  , C in a fridge short term in a concentrated dilution, In children, Symptoms can be mild to severe, The most common , This antibody needs to be stored at + 4°, and , caused by an , coughing, feeling tired, fever, flu", headache, infectious disease , influenza virus, muscle pains, nausea , runny nose, sore throat, symptoms include a high , the , vomiting
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24°
Conjugationhistidine
Gene target His-tagged), Influenza A H5N1 Vietnam 1203/04 Hemagglutinin (17-338
Short name His-tagged) Antibody, anti-Influenza A H5N1 Vietnam 1203/04 Hemagglutinin (17-338
Technique antibodies against human proteins, antibodies for, antibody to, Antibody
LabelHis
Species Influenza, Influenza
Alternative name histidine-tagged) (Antibody to), antibody to-Influenza A H5N1 Vietnam 1203/04 Hemagglutinin (17-338
Alternative techniqueantibodies

Subscribe to our Newsletter